Member Info for Elsol

Not necessarily so Bruce. Mutations are random in nature and can take viral severity up or down quite by chance, especially if they jump several mutation steps at once. Look at some of the worst influenza outbreaks during the last few hundred years...as one example. Are we saying flu will gradually disappear as a potentially harmful pathogen...nope. Guess again. We are already seeing vaccine infectious creep around for SARS cov2. Creeping mutations also create larger jumps that kick start a bad variant.

The historical global wave nature of mutant variants establishing themselves appears to be around every 4 to 6 months between peaks tracing back since the ground zero China incident.
Now, my theory is as follows;
1. Mutation creation is a direct correlation with number of infections given same probability chance of mutation rate for each person infected
2. There is a seasonal effect but globally does not seem to be that significant or overwhelming ( eg still get peaks in summer)
3. The increased case rate globally now with higher transmission rate probably means a reduced time for new virulent mutations to be created with a compressed time between peaks and troughs !!

So next viral peak probably will be here in around 3 to 4 months. Could be longer , could be shorter but that's my best guess.

Thx Tommy interesting reading summary

This has to be a good measured risk adjusted stock buy right now at this tiny price. Oil expensive, feedstock of many products ITX are aiming to replace with greener alternatives. It's got to be counter cyclical in present market landscape and outlook

Read "now" not "Not" autocorrected!! ;-)

Correct xviolet , It's genetic evolution, SARS Cov2 has been in other global species evolving in symbiosis for millennia ....why would 2022 change this dynamic? Not its majorly into humans and its never going away just like genital herpes.

One battle lost with phase 3 sprinter but war is not lost. We know IT works . ..its taken millions of years of evolution to get to SNG001 and I'm holding for realisation of that reality. Good luck if you decide to offload to Polygon at this tiny price but I'm HOLDING on

AETHER. they saw the last 2 years of market facts and company science that's it like you and me.

Certainly makes me think my OLD BMW z4 needs trading in for an electric scooter

Good note AJP. I agree we are sat well for now on this company with lots of upside driven off this awful humanitarian disaster and the oil price issue that will catalyse more long term substitution to cheaper green products ingredients. Just waiting for news announcements to flow our way on this front. Good luck all.

Andyb4. "It’ll take another 3-5 years to set up another trial and do another fund raise"
Are you on drugs? Utter RUBBISH.

Real world evidence NOT rural!!! :-)

Mentions genetic dysfunctional interferon gene closely linked to severe covid illness. Just more scientific evidence in this study based on rural world evidence on 1000s of DNA samples from severe, mild and asymptomatic people

https://www.google.com/url?sa=t&source=web&rct=j&url=https://news.sky.com/story/amp/covid-19-new-study-could-lead-to-life-saving-treatment-for-severe-cases-12560046&ved=2ahUKEwj2p72R-bT2AhWQzYUKHUsRDoEQFnoECAcQAQ&usg=AOvVaw29rAmKZzp3pNryXeT004kX

Isnt it important also in the round to look whether there are patterns in the treated v's non treated arms in discrete country segments and look for correlation. This also may indicate an unusual highly improbable result that means or indicates beyond reasonable doubt that SNG001 results are stat significant (e.g. imagine if EACH country data shows that there were NEVER a circumstance at a COUNTRY level where "treatment arm" deaths or severe disease were higher than non-treatment arm. Then do the same analysis on the prior phase II and the ACTIV 2 if possible to cross correlate. If this were the case I think (non stats view) that a proof of significance could theoretically be pulled over the line.

My god she (or he) types automatically on these threads and gets around faster than the next version of Omicron C.235 !!!!
Stay short and buy later no worries....:-)

Its a fact - anyone fancy going through 2000-early 2022 ONCE AGAIN? NO! - thought not.
This is going up again big style soonish just wait....burning embers are lit

I think the value on the downside is pretty much under-pinned by the "heavy current discount" to the large historic R&D investment ITX have made over many years coupled with all the intangible asset (IA) value off balance sheet from blue chip customer acquisition and continuing relationship/chemistry development. So for me all of the material SP volatility is on the upside - its got to go north from here IMO; especially if there are further contract roll outs announced in the near term.

To coin your choppy waters analogy Kevin, would you expect the captain to leave the bridge of the ship at a critical time to chat to the fare paying passengers?? Of course not he's working 110% to get us back into safe waters

Thank you. Excellent reply.